Can diclofenac be prescribed to patients with hypertension?

Diclofenac Should Be Avoided in Patients with Hypertension

Diclofenac can be prescribed to hypertensive patients only with extreme caution and close monitoring, but it is generally not recommended due to significant cardiovascular risks and blood pressure elevation—consider alternative analgesics first.

Key Evidence from FDA Labeling and Guidelines

The FDA drug label explicitly warns that NSAIDs, including diclofenac, can lead to new onset hypertension or worsening of preexisting hypertension, which may contribute to increased cardiovascular events 1. This is not a theoretical concern—the evidence shows diclofenac carries one of the highest cardiovascular risks among NSAIDs.

Cardiovascular Risk Profile

Diclofenac demonstrates particularly concerning cardiovascular data compared to other NSAIDs:

• Meta-analysis of RCTs showed diclofenac increased vascular events with RR 1.63 (95% CI 1.12-2.37) 2
• Registry data revealed recurrent MI risk of RR 1.54 and mortality risk of RR 2.40—the highest among commonly used NSAIDs 2
• These risks are substantially higher than naproxen (RR 0.92 for vascular events) and comparable to selective COX-2 inhibitors 2

Blood Pressure Effects

Multiple studies confirm diclofenac's hypertensive effects:

• Mean systolic BP increase of 8.5 mmHg and diastolic BP increase of 2.4 mmHg in hypertensive patients 3
• Blood pressure elevation occurred in 12% of hypertensive patients on diclofenac 3
• The drug blunts the effectiveness of ACE inhibitors, ARBs, beta-blockers, and diuretics 1, 4

A critical study showed that when diclofenac was combined with lisinopril in hypertensive patients, blood pressure control was significantly reduced (p=0.00002 for systolic, p=0.000008 for diastolic) compared to lisinopril alone 4.

Clinical Decision Algorithm

If Diclofenac Must Be Used in Hypertensive Patients:

1. Assess cardiovascular risk factors:

   • Contraindicated if: prior MI, stroke, PAD, CHF, or CABG surgery 1, 5
   • High caution if: diabetes, hyperlipidemia, age ≥65, or multiple CV risk factors 6, 7

2. Monitor blood pressure rigorously:

   • Check BP at initiation and throughout therapy 1
   • Expect mean increases of 5 mmHg or more 6
   • Adjust antihypertensive medications proactively

3. Optimize antihypertensive regimen:

   • Calcium channel blockers appear to maintain efficacy better than other classes when combined with NSAIDs 7, 8
   • ACE inhibitors and ARBs show reduced effectiveness with concurrent NSAID use 4

4. Use lowest effective dose for shortest duration 1

5. Monitor renal function:

   • Check serum creatinine, BUN, and electrolytes 1
   • Risk of hyperkalemia, especially with ACE inhibitors/ARBs 1
   • Hypertensive patients show exacerbated renal damage with diclofenac 9

Critical Pitfalls to Avoid

• Do not assume all NSAIDs are equivalent: Diclofenac has higher CV risk than naproxen or ibuprofen 2
• Do not ignore the drug interaction: Patients on ACE inhibitors, ARBs, or diuretics will have impaired antihypertensive response 1, 4
• Do not prescribe long-term: CV risk increases with duration of use 1
• Do not overlook renal function: Hypertensive patients are at higher risk for NSAID-induced renal dysfunction 9

Preferred Alternatives

When pain control is needed in hypertensive patients:

• Acetaminophen as first-line (though monitor for hepatotoxicity with chronic use)
• Naproxen if NSAID required—lowest CV risk among NSAIDs (RR 0.92) 2
• Topical NSAIDs for localized musculoskeletal pain
• Consider non-pharmacologic approaches

Regulatory Context

The 2013 European Medicines Agency regulatory action specifically targeted diclofenac use in patients with cardiovascular disease, including hypertension 10, 5. Despite these warnings, inappropriate prescribing continues, with studies showing 31.7% of hypertensive outpatients still receiving NSAIDs 11. The FDA black box warning emphasizes the cardiovascular thrombotic risk that increases with duration of use 2.

Bottom line: While not absolutely contraindicated in uncomplicated hypertension, diclofenac should be reserved for situations where benefits clearly outweigh risks, alternative analgesics have failed, and intensive BP/renal monitoring can be implemented.